Abstract
Lymphomatoid granulomatosis is a rare lymphoproliferative disorder involving the lungs, skin and other organs. Advanced-stage disease does not tend to respond well to cytotoxic chemotherapy and is associated with a poor prognosis. We present a case of successful treatment of relapsed lymphomatoid granulomatosis with bexarotene, a novel retinoid agent. ©2008 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Berg, S. E., Downs, L. H., Torigian, D. A., Chong, E. A., Tsai, D. E., Wasik, M. A., & Schuster, S. J. (2008). Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene. Cancer Biology and Therapy, 7(10), 1544–1546. https://doi.org/10.4161/cbt.7.10.6834
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free